Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Interesting news from Avicanna

<< Previous

Bullboard Posts

Next >>

Comment by alleyesonmeon Feb 13, 2024 10:53am

107 Views

Post# 35877561

RE:RE:RE:RE:Interesting news from Avicanna

Very interesting, 10% Cannabidiol (CBD) as opposed to 90%epidiolex, this drug would fall under 505b2 through FDA application, Avicanna /Labs, close business relationship aforementioned in the expanded partnership agreement announced by avicanna but never mentioned by Labs....also makes you wonder in addition to the medical products coming to Brazil what will be the pharmaceutical drug that Labs obtained the pharmaceutical GMP certification for in Brazil...this stock is so loaded, ready to explode on developments.

<< Previous

Bullboard Posts

Next >>

Understanding tax loss season and the “Santa Claus rally”